我国公立医疗机构药品价格虚高及体制原因探析

Analysis of Nominal High Price of Drug in Public Medical Institutions in China

自1997年以来,国家发改委先后20多次降低药品价格,每次平均大概降了15%~20%,一部分药品最高降价幅度达到60%左右,但并没有真正降低老百姓的药品消费和解决＂看病贵＂的难题。药品价格虚高问题不单纯是价格问题,而是一个体制机制问题。药品价格不合理是医药卫生体制和经济运行中各种矛盾的集中反映。

Since 1997,the National Development and Reform Commission has reduced drug prices over 20 times,with each time the average dropped by about 15% ～20%,with the highest decline about 60%.The ＂expensive in seeing a doctor＂problem of high drug consumption has not been solved.Nominal high price of drug is not a simple issue,but the problem of institutional mechanism.The unreasonable prices of drug is the concentrated reflection of contradictions in medical health system and economic operation.